Bone marrow biopsy did not show JAK2, CALR or MPL mutations and there was no typical myelofibrosis or abnormal megakaryocyte hyperplasia, which excludes the possibility of myeloproliferative neoplasms. This evidence concerns the gene MPL and myeloproliferative neoplasm.